Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival

This publication has 27 references indexed in Scilit:

• Cytomegalovirus viremia associated with death or retransplantation in pediatric lung-transplant recipients
  Transplantation, 2003
• Has cytomegalovirus infection any role in the development of atherosclerosis?
  Clinical Microbiology & Infection, 2002
• CYTOMEGALOVIRUS DISEASE IS NOT A MAJOR RISK FACTOR FOR ISCHEMIC HEART DISEASE AFTER RENAL TRANSPLANTATION1
  Transplantation, 2001
• Area under the viraemia curve versus absolute viral load: Utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients
  Journal of Medical Virology, 2001
• Preemptive Therapy Versus Universal Prophylaxis with Ganciclovir for Cytomegalovirus in Solid Organ Transplant Recipients
  Clinical Infectious Diseases, 2001
• A PROSPECTIVE STUDY OF THE NATURAL COURSE OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN RENAL ALLOGRAFT RECIPIENTS1
  Transplantation, 2000
• Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival
  Transplant International, 2000
• Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes
  European Journal of Clinical Microbiology & Infectious Diseases, 1998
• GLUCOSE INTOLERANCE AFTER RENAL TRANSPLANTATION DEPENDS UPON PREDNISOLONE DOSE AND RECIPIENT AGE1
  Transplantation, 1997
• Association between Prior Cytomegalovirus Infection and the Risk of Restenosis after Coronary Atherectomy
  New England Journal of Medicine, 1996